Titre:
  • Phase II study of the antibody-drug conjugate TAK-264 (MLN0264) in patients with metastatic or recurrent adenocarcinoma of the stomach or gastroesophageal junction expressing guanylyl cyclase C
Auteur:Almhanna, Khaldoun; Bendell, Johanna; Firdaus, Irfan; Messersmith, Wells; Ye, Zhan; Fasanmade, Adedigbo A.A.; Danaee, Hadi; Kalebic, Thea; Miron, Maria Luisa Limon; Wright, David; Gracian, Antonio Cubillo; Hubner, Richard R.A.; Van Laethem, Jean-Luc; López, Carolina Muriel; Alsina, Maria; Muñoz, Frederico Longo
Informations sur la publication:Investigational new drugs, 35, 2, page (235-241)
Statut de publication:Publié, 2017-04
Sujet CREF:Cancérologie
Pharmacologie
Mots-clés:Antibody–drug conjugate
Gastrointestinal cancer
Guanylyl cyclase C
TAK-264
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0167-6997
info:doi/10.1007/s10637-017-0439-y
info:scp/85012198774